Ordaos
New York, NY, United States ordaos.bio From their website, Nov 2026
Work here? Claim this listing
About
Ordaos designs small proteins and biologics using an AI-driven, lab-in-the-loop platform. It works with partners on rapid discovery and optimization programs for therapeutics and related protein applications from its site in Long Island City, New York.
Ordaos is based in New York, NY. It lists 7 services, including AI-driven protein design, Rapid lab-in-the-loop testing and Mini-protein discovery.
Services
AI-driven protein design
Uses a multi-agentic LLM system to generate and screen novel protein designs.
Rapid lab-in-the-loop testing
Makes and tests candidate proteins in its proprietary cell-free protein expression system and runs them through laboratory assays.
Mini-protein discovery
Rapidly discovers high-value small protein candidates, including de novo mini-proteins and miniPRO binders.
Protein optimization
Optimizes existing protein formats such as VHH antibodies using generative AI.
De novo mini-protein design
Creates novel mini-proteins from scratch using its Design Engine and AI-driven sequence and structure generation.
Single domain antibody optimization
Optimizes single domain VHH antibodies for target binding and developability using generative AI.
Therapeutic candidate design for target profiles
Translates human-defined molecular target product profiles into designed miniPRO candidates.
- Turnaround
- 5 days
- Within weeks
How to order from Ordaos
Turnaround they state: 5 days; Within weeks. They take requests through the contact form on their website. You can contact them directly from this page, or request a quote through Midgard.
Capabilities
- Assays and studies
- Antibodies
- Immunogenicity
- Binding affinity
- Binding kinetics
- Binding durability
- Off-target interactions
14 more
- Thermal stability
- Chemical stability
- Structural integrity
- Freeze-thaw resilience
- Oxidation resistance
- Shear stress tolerance
- Cytotoxicity
- Accumulation risk
- Allergenic potential
- Metabolite toxicity
- Binding specificity
- Solubility
- Stability
- Developability
- Scale and capacity
- 200 mini-proteins per round
- Therapeutic areas
- Metabolic disorder
- Infectious disease
- NTM
- Drug discovery
- Therapeutics
Modalities and species
- Modalities
- Antibody
- Species and models
- Cell-free protein expression system
Details
- Address
- 228 Park Ave S 60684, New York, NY 10003, USA
- Sites
- Long Island City, USA